Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical subcutaneous ropivacaine injection for postoperative pain after laparotomy
IRCT20220108053667N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Patient pain control after surgery. Started Jan 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220108053667N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220108053667N1.